Publications

Our scientific publications in high-quality journals reflect the quality of the innovative research in Entasis’ laboratories.

Search by Program

Rodvold KA, Gotfried MH, Isaacs RD, O'Donnell JP, Stone E

Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects

AAC Accepted Manuscript Posted Online 20 August 2018

Damião Gouveia, A.C., Unemo, M. and Jensen, J.S.

In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains

J Antimicrobial Chemotherapy doi:10.1093/jac/dky022 (2018)

S. McLeod, A. Shapiro, S. Moussa, M. Johnstone, R. McLaughlin, B. de Jonge and A. Miller

Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii

Antimicrob. Agents Chemother. February 2018 vol. 62 no. 2 e01576-17

Adam B. Shapiro, Ning Gao, Haris Jahić, Nicole M. Carter, April Chen, and Alita A. Miller.

Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514

ACS Infectious Diseases (2017)

Iyer R, Sylvester M, Velez-Vega C, Tommasi R, Durand-Réville T, Miller A*

Whole-Cell-Based Assay To Evaluate Structure Permeation Relationships for Carbapenem Passage through the Pseudomonas aeruginosa Porin OprD

ACS Infectious Diseases (2017)

Papp JR, Lawrence K, Sharpe S, Mueller J, Kirkcaldy R

In vitro growth of multidrug-resistant Neisseria gonorrhoeae isolates is inhibited by ETX0914, a novel spiropyrimidinetrione

International Journal of Antimicrobial Agents (2016)